Current Pain and Headache Reports

, Volume 6, Issue 2, pp 151–155

Should butalbital-containing analgesics be banned? Yes.

Authors

  • William B. Young
    • Jefferson Headache CenterDepartment of Neurology, Thomas Jefferson University
  • Hua Chiang Siow
    • Jefferson Headache CenterDepartment of Neurology, Thomas Jefferson University
Article

DOI: 10.1007/s11916-002-0012-y

Cite this article as:
Young, W.B. & Siow, H.C. Current Science Inc (2002) 6: 151. doi:10.1007/s11916-002-0012-y

Abstract

In the United States analgesic-overuse headache is often caused by butalbital-containing analgesics. These agents can cause physical and psychological dependency, and dangerous withdrawal syndromes. Butalbital-containing analgesics have already been banned in several European countries. They are proven effective in tension-type headache, but not in migraine; there are many alternative treatments for migraine and tension-type headache. In the 20 years since analgesic overuse headache was widely recognized, butalbital overuse has remained distressingly common. It is time to ban these agents.

Copyright information

© Current Science Inc 2002